Click Here for COVID-19 Information
  • RX Refill/Transfer
  • Online Bill Pay
  • Contact
  • Skip to primary navigation
  • Skip to main content
  • Skip to footer

Kohlls Rx

Locally owned and operated since 1948.

402-408-1990 / 866-500-7800
  • Home Medical Equipment
    • Aids to Daily Living
    • Apparel
    • Bathroom Modifications for Seniors
    • Bedroom
    • Lifts & Assists
    • Home Modifications
    • Mobility
    • Respiratory
    • Urological
    • Wheelchair Vans
  • Pharmacy
    • Corporate Wellness
    • Fertility Drugs
    • Assisted Living Facility & Group Homes Endorsement
    • Pharmaceutical Packaging
    • Prescription Refills
    • Laboratory
    • Specialty Medications
    • Vaccines & Flu Shots
    • COVID-19, Flu, Strep, and RSV Information
  • About Kohll’s Pharmacy
    • About Kohll’s Pharmacy
    • Locations
    • Careers
    • Pay Your Bill Online
    • Financing Options
    • Contact Us
  • Vaccines
  • COVID-19
    • General Information
    • Vaccinations
    • Testing
    • Treatments
    • Corporate Clinics
  • Home
New COVID-19 Treatment Clinic at Kohll’s Rx

New COVID-19 Treatment Clinic at Kohll’s Rx

January 1, 2022 by Yufei Shi, Pharm.D. Candidate University of Nebraska Medical Center, 2022, Andrew Schleisman, Pharm.D., David Kohll, Pharm.D.

A COVID-19 monoclonal antibody (MAB) treatment clinic is necessary to treat newly active cases of COVID. These clinics meet the needs of the community during this time of increased infection rates and hospitalization. MABs are designed to directly bind to the COVID-19 virus, helping prevent the progression of the disease.

Currently, there are three products authorized by the US Food and Drug Administration (FDA) for the emergency use for COVID-19 treatment outside the hospital. Emergency use authorization (EUA) is different from FDA approval. The purpose of EUA medication is to provide more timely access to critical medical products during the emergency when approved alternative options are not available. download ativador windows 10 The three products with EUA in outpatient COVID-19 treatment are bamlanivimab + etesevimab, casirivimab + imdevimab, and sotrovimab. Casirivimab + imdevimab is also indicated for post-exposure prophylaxis in vulnerable populations. Kohll’s Rx has a MAB treatment clinic and uses casirivimab + imdevimab treatment at their Millard clinic location.

Who can receive the treatment? The EUA provides specific requirements. Casirivimab + imdevimab should be used in medium to high risk adult or pediatric patients at least 12 years old and weighing at least 88 lbs. Common high risk factors include advanced age, obesity (BMI 25 or greater), pregnancy, diabetes, chronic kidney disease, chronic lung disease, and immunosuppressive disease. Since it is most effective when given early in infection, when used in mild and moderate infections, treatment should be given as soon as possible following the positive COVID-19 PCR or antigen test. It must be given within 10 days of symptom onset. Patients who are hospitalized, require oxygen therapy due to COVID-19 infection, or require increased baseline oxygen flow rate due to COVID-19 infections are not authorized to receive this treatment. For post-exposure prophylaxis of COVID-19 treatment, patients have to be immunocompromised or not fully vaccinated, and have been exposed or at high risk of exposure to a COVID-19 infected individual.

Qualified patients with or without a provider’s referral can make an appointment for the COVID-19 monoclonal antibody treatment at Kohll’s Rx. At the clinic, patient demographic information will be collected and questions will be addressed before the treatment. A full dose of casirivimab + imdevimab includes 4 injections given subcutaneously usually at the back of each upper arm and each side of the abdomen. The most common side effect for the product appears to be injection site pain. office 2013 download português + ativador gratis This product is investigational and clinical trials for safety and efficacy are ongoing. To help catch the early adverse effects, patient’s vitals will be checked before, after, and 60 minutes post-administration. Written information about the treatment is given to all patients who received this treatment at our clinic.

This MAB treatment is by no means a substitute for vaccination. However, it is exciting that we are able to offer it to our patients. So far, many patients are reporting an improvement in their symptoms within a few days. Hopefully, with this treatment, more patients with mild to moderate symptoms can be prevented from infection progression and hospitalization.

Other Recent Articles

Over the Counter Hearing Aids are Here!

What You Should Know About CBD

Walk-in Tubs Elegance and Safety

Grab Bar Installation & Picking the Right Style

New Vaccine Recommendations for Older Adults

Kohll's Pharmacy & Homecare'

Kohll's has been serving patients in Omaha, Lincoln and western Iowa since 1948. We provide high-quality service to better your health.

Footer

Join Our Mailing List Facebook Twitter LinkedIn

Quick Links:

  • RX Refill / Transfer
  • Online Bill Pay
  • Contact Us
  • Home Medical Equipment
  • Patient Information and Compliance Documents
  • Pharmacy
  • Events
  • Articles
  • News

Locations:

Do you have COVID-19 questions? Use our Contact Form to receive the quickest response.

Call 402-973-1947 for our COVID-19 team.

  • 2915 Leavenworth St / 402-342-6548
  • 12741 Q St / 402-895-3102
  • 5002 Dodge St / 402-553-8901
  • 808 N 27th St (Lincoln) / 402-476-3342
  • 403 Main St (Malvern) / 712-624-9050
View all Hours & Locations >
© Kohlls Rx - All rights reserved.
  • About Kohll’s Pharmacy
  • Careers
  • Pay Your Bill Online
  • Privacy Policy